| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Departments of Ophthalmology and Immunology, Schepens Eye Research Institute, Boston, MA 02114; and
Transplantation Unit, Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02113
Corneal grafts were until recently considered entirely devoid of resident APCs, giving rise to the tenet that alloantigen recognition is mediated exclusively by the indirect (host APC-dependent) pathway. The recent discovery of a resident myeloid corneal dendritic cell population that is normally MHC class II– but can readily up-regulate class II expression during inflammation led us to hypothesize that under certain conditions the direct pathway of allosensitization becomes operative. To test this, corneal allotransplants were performed in either inflamed (high-risk (HR)) or uninflamed (low-risk (LR)) host beds in mice, and the frequencies of host T cells activated via the direct pathway were determined. We found that directly primed CD4+ T cells were detected in the HR but not LR setting, and these cells displayed a clear Th1 phenotype by 2 wk after grafting. Moreover, the use of MHC class II knockout donor tissue led to significantly enhanced survival of HR but not LR allografts. Finally, we show that donor corneal APC demonstrate high expression of CD40, CD80, and CD86 costimulatory molecules when derived from HR but not LR grafts. These data are the first to report that a functional donor APC-dependent direct response is elicited in corneal transplant hosts when the graft bed is inflamed and underscore the relevance of the graft microenvironment in dictating the pathway of allosensitization.
This article has been cited by other articles:
|
|
 |
|
  X. Zhang, L. Shen, Y. Jin, D. R. Saban, S. K. Chauhan, and R. Dana Depletion of Passenger Leukocytes from Corneal Grafts: An Effective Means of Promoting Transplant Survival? Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3137 - 3144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-S. Chung, D. R. Saban, S. K. Chauhan, and R. Dana Regulation of Blood Vessel versus Lymphatic Vessel Growth in the Cornea Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1613 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Chauhan, D. R. Saban, H. K. Lee, and R. Dana Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation J. Immunol., January 1, 2009; 182(1): 148 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kuffova, M. Netukova, L. Duncan, A. Porter, B. Stockinger, and J. V. Forrester Cross Presentation of Antigen on MHC Class II via the Draining Lymph Node after Corneal Transplantation in Mice J. Immunol., February 1, 2008; 180(3): 1353 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shen, Y. Jin, G. J. Freeman, A. H. Sharpe, and M. R. Dana The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival J. Immunol., September 15, 2007; 179(6): 3672 - 3679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hamrah, S. Yamagami, Y. Liu, Q. Zhang, S. S. Vora, B. Lu, C. J. Gerard, and M. R. Dana Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1228 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamagami, N. Ebihara, T. Usui, S. Yokoo, and S. Amano Bone Marrow-Derived Cells in Normal Human Corneal Stroma Arch Ophthalmol, January 1, 2006; 124(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamagami, S. Yokoo, T. Usui, H. Yamagami, S. Amano, and N. Ebihara Distinct Populations of Dendritic Cells in the Normal Human Donor Corneal Epithelium Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4489 - 4494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
